The survival curve seemed different between the RNF43 wild-type group and the RNF43 mutant group, and log-rank univariate survival analysis showed a significant difference in invasive IPMN patients (P = 0.002) (Figure 2). Here, RNF43 is linked to pancreatic intraductal papillary-mucinous neoplasm.